Insight Molecular Diagnostics Inc. (IMDX) Operating income 2016–2025
Insight Molecular Diagnostics Inc. (IMDX) annual operating income history from SEC filings — each fiscal year as reported.
-$51.1MFY2025 · since FY2016: -$11.1M → -$51.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.1M | +16.2% |
| FY2024 | -$61.0M | -142.8% |
| FY2023 | -$25.1M | -39.7% |
| FY2022 | -$18.0M | +66.5% |
| FY2021 | -$53.7M | -80.8% |
| FY2020 | -$29.7M | -33.6% |
| FY2019 | -$22.2M | -46.3% |
| FY2018 | -$15.2M | +19.3% |
| FY2017 | -$18.8M | -69.2% |
| FY2016 | -$11.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice